MeSH 搜索器

Clinical Trials, Phase I as Topic

Works about studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.
推出的年份: 2008(1993)
副标题
树号: E05.318.372.250.250.200, N05.715.360.330.250.250.200, N06.850.520.450.250.250.200
MeSH 单一 ID: D017321
进入的组:
  • Phase I Clinical Trial
  • Phase 1 Clinical Trials
  • Clinical Trials, Phase I
  • Clinical Trials, Phase 1
  • Phase 1 Clinical Trial
  • Phase I Clinical Trials
  • Evaluation Studies, FDA Phase I
  • Evaluation Studies, FDA Phase 1
  • Microdosing Trials, Human
  • Human Microdosing Trials
  • Human Microdosing Trial
  • Microdosing Trial, Human
  • Trial, Human Microdosing
  • Trials, Human Microdosing
  • Drug Evaluation, FDA Phase I as Topic
  • Drug Evaluation, FDA Phase 1
  • Drug Evaluation, FDA Phase I
早前的内容:
  • Clinical Trials (1980-1992)
  • Drug Evaluation (1980-1992)

留言 (0)

沒有登入
gif